8 in 8: Biomarker Testing and Neoadjuvant Immunotherapy for Resectable NSCLC
Society of Thoracic Surgeons - Surgeon
MAY 23, 2024
Video 8 in 8: Biomarker Testing and Neoadjuvant Immunotherapy for Resectable NSCLC kchalko Thu, 05/23/2024 - 09:56 In this video in the 8 in 8 Series, Dr. Dwight Owen (Ohio State University) discussed advances in biomarker testing and neoadjuvant immunotherapy for resectable non-small cell lung cancer. Supported by AstraZeneca.
Let's personalize your content